{"id":"https://openalex.org/W2895846053","doi":"https://doi.org/10.1055/a-0748-5745","title":"Effect of Canagliflozin on Heart Function Involving Ketone Bodies in Patients with Type 2 Diabetes","display_name":"Effect of Canagliflozin on Heart Function Involving Ketone Bodies in Patients with Type 2 Diabetes","publication_year":2018,"publication_date":"2018-10-08","ids":{"openalex":"https://openalex.org/W2895846053","doi":"https://doi.org/10.1055/a-0748-5745","mag":"2895846053","pmid":"https://pubmed.ncbi.nlm.nih.gov/30296805"},"language":"en","primary_location":{"id":"doi:10.1055/a-0748-5745","doi":"https://doi.org/10.1055/a-0748-5745","is_oa":true,"landing_page_url":"https://doi.org/10.1055/a-0748-5745","pdf_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-0748-5745.pdf","source":{"id":"https://openalex.org/S4210226141","display_name":"Drug Research","issn_l":"2194-9379","issn":["2194-9379","2194-9387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-0748-5745.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015460546","display_name":"Eiji Kutoh","orcid":"https://orcid.org/0009-0009-3873-9568","observed_orcids":["https://orcid.org/0009-0009-3873-9568"]},"institutions":[{"id":"https://openalex.org/I4405254371","display_name":"Gyoda General Hospital","ror":"https://ror.org/01qw7w969","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405254371"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Eiji Kutoh","raw_affiliation_strings":["Division of Clinical Research, Biomedical Center, Tokyo, Japan","Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan","Division of Diabetes and Metabolism, Department of Internal Medicine, Higashitotsuka Memorial Hospital, Yokohama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Research, Biomedical Center, Tokyo, Japan","institution_ids":[]},{"raw_affiliation_string":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan","institution_ids":["https://openalex.org/I4405254371"]},{"raw_affiliation_string":"Division of Diabetes and Metabolism, Department of Internal Medicine, Higashitotsuka Memorial Hospital, Yokohama, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070028378","display_name":"Jyunka Hayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254371","display_name":"Gyoda General Hospital","ror":"https://ror.org/01qw7w969","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405254371"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jyunka Hayashi","raw_affiliation_strings":["Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Gyoda General Hospital, Saitama, Japan","institution_ids":["https://openalex.org/I4405254371"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5015460546"],"corresponding_institution_ids":["https://openalex.org/I4405254371"],"apc_list":null,"apc_paid":null,"fwci":1.6361,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.83026474,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"69","issue":"05","first_page":"297","last_page":"300"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":1.0},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.953000009059906},{"id":"https://openalex.org/keywords/cardiac-function","display_name":"cardiac function","score":0.8859999775886536},{"id":"https://openalex.org/keywords/ketone-bodies","display_name":"ketone bodies","score":0.8920000195503235},{"id":"https://openalex.org/keywords/acetoacetate","display_name":"acetoacetate","score":0.7820000052452087},{"id":"https://openalex.org/keywords/beta-hydroxybutyrate","display_name":"beta-hydroxybutyrate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ejection-fraction","display_name":"ejection fraction","score":0.9629999995231628},{"id":"https://openalex.org/keywords/myocardial-shortening","display_name":"myocardial shortening","score":0.6349999904632568},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.7360000014305115},{"id":"https://openalex.org/keywords/cardiometabolic-effects","display_name":"cardiometabolic effects","score":0.7480000257492065}],"concepts":[{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.9352031946182251},{"id":"https://openalex.org/C31532488","wikidata":"https://www.wikidata.org/wiki/Q746183","display_name":"Ketone bodies","level":3,"score":0.7598358988761902},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6091693043708801},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5999473333358765},{"id":"https://openalex.org/C111566952","wikidata":"https://www.wikidata.org/wiki/Q1303462","display_name":"Cardiac function curve","level":3,"score":0.5876542329788208},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5295965075492859},{"id":"https://openalex.org/C2779384505","wikidata":"https://www.wikidata.org/wiki/Q17007513","display_name":"Concomitant","level":2,"score":0.5232240557670593},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.4954777956008911},{"id":"https://openalex.org/C2777738585","wikidata":"https://www.wikidata.org/wiki/Q170744","display_name":"Ketone","level":2,"score":0.4205949306488037},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.3723104000091553},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3410949409008026},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2737605571746826},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.1824033260345459},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.1656332015991211},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000068896","descriptor_name":"Canagliflozin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004452","descriptor_name":"Echocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006321","descriptor_name":"Heart","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007657","descriptor_name":"Ketone Bodies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009206","descriptor_name":"Myocardium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013318","descriptor_name":"Stroke Volume","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/a-0748-5745","doi":"https://doi.org/10.1055/a-0748-5745","is_oa":true,"landing_page_url":"https://doi.org/10.1055/a-0748-5745","pdf_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-0748-5745.pdf","source":{"id":"https://openalex.org/S4210226141","display_name":"Drug Research","issn_l":"2194-9379","issn":["2194-9379","2194-9387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Research","raw_type":"journal-article"},{"id":"pmid:30296805","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30296805","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug research","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1055/a-0748-5745","doi":"https://doi.org/10.1055/a-0748-5745","is_oa":true,"landing_page_url":"https://doi.org/10.1055/a-0748-5745","pdf_url":"http://www.thieme-connect.de/products/ejournals/pdf/10.1055/a-0748-5745.pdf","source":{"id":"https://openalex.org/S4210226141","display_name":"Drug Research","issn_l":"2194-9379","issn":["2194-9379","2194-9387"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Research","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2895846053.pdf","grobid_xml":"https://content.openalex.org/works/W2895846053.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W2033807650","https://openalex.org/W2068171948","https://openalex.org/W2108712459","https://openalex.org/W2146264128","https://openalex.org/W2297835124","https://openalex.org/W2412800896","https://openalex.org/W2416348735","https://openalex.org/W2508449087","https://openalex.org/W2532735232","https://openalex.org/W2553261268","https://openalex.org/W2626446274","https://openalex.org/W2647200573","https://openalex.org/W4235067302"],"related_works":["https://openalex.org/W4235067302","https://openalex.org/W4408383310","https://openalex.org/W2948029031","https://openalex.org/W4310067748","https://openalex.org/W2920640015","https://openalex.org/W2965629332","https://openalex.org/W2948400088","https://openalex.org/W2806818105","https://openalex.org/W3171448871","https://openalex.org/W3135572200"],"abstract_inverted_index":{"This":[0,135],"report":[1],"describes":[2],"the":[3],"effect":[4],"of":[5,11,36],"administration":[6],"(n=3)":[7],"or":[8,132],"withdrawal":[9],"(n=2)":[10],"canagliflozin,":[12],"a":[13],"sodium-glucose":[14],"co-transporters":[15],"2":[16],"(SGLT-2)":[17],"inhibitor,":[18],"on":[19,140],"cardiac":[20,141],"function":[21,38,77,128,142],"in":[22],"relation":[23],"to":[24],"ketone":[25,52,124,145],"bodies.":[26,146],"Three":[27],"cases":[28,32],"received":[29,78],"and":[30,44,48,62,70,84,89,96,100,111,126],"two":[31],"discontinued":[33,105],"canagliflozin.":[34],"Changes":[35],"heart":[37,76,102,127],"with":[39,73,98,131],"ultrasonography":[40],"(EF:":[41],"ejection":[42],"fraction":[43],"%FS:":[45],"functional":[46],"shortening)":[47],"cardiometabolic":[49],"parameters":[50],"including":[51],"bodies":[53,125],"(acetoacetate/beta-hydroxybutylate)":[54],"were":[55,129],"compared":[56],"at":[57],"3":[58],"months.":[59],"69,":[60],"68":[61],"60":[63,88],"years":[64,91],"old":[65,92],"male":[66],"patients":[67,94],"A,":[68],"B":[69],"C,":[71],"respectively":[72,104],"moderately":[74],"decreased":[75],"canagliflozin":[79,106],"100":[80],"mg/day.":[81,108],"EF,":[82,109],"%FS":[83,110],"acetoacetate/beta-hydroxybutylate":[85,112],"levels":[86,113],"increased.":[87],"59":[90],"female":[93],"D":[95],"E":[97],"normal":[99],"borderline":[101],"function,":[103],"50":[107],"decreased.":[114],"Taken":[115],"together,":[116],"these":[117],"results":[118],"suggest":[119],"that":[120],"concomitant":[121],"changes":[122],"between":[123],"observed":[130],"without":[133],"canagliflzoin.":[134],"drug":[136],"might":[137],"have":[138],"effects":[139],"through":[143],"modulating":[144]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-10-26T00:00:00"}